%0 Journal Article
%@ 1565-1088
%A Byrne, A
%A Lambert, J
%A Yellon, D
%A Walker, M
%A Sivabalasingham, S
%A Ghosh, AK
%D 2022
%F discovery:10152100
%I ISRAEL MEDICAL ASSOC JOURNAL
%J Israel Medical Association Journal
%K cardiology, cardiotoxicity, lymphoma, oncology, pre-assessment
%N 3
%P 159-164
%T Cardio-oncology Issues in Lymphoma Patients
%U https://discovery.ucl.ac.uk/id/eprint/10152100/
%V 24
%X Advances in Lymphoma management have resulted in significant improvements in patient outcomes over the last 50 years. Despite these developments, cardiotoxicity from lymphoma treatments remains an important cause of mortality and morbidity in this cohort of patients. We outlined the most common cardiotoxicities associated with lymphoma treatments and their respective investigation and management strategies, including the role of cardiac pre-assessment and late effects monitoring.
%Z This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.